Everything you need to know about our Fusion-detect™ blood-based liver cancer screening test.
The MoleculeDx test screens specifically for hepatocellular carcinoma (HCC) — the most common form of primary liver cancer, accounting for 75–85% of all liver cancer cases in the US.
We analyze circulating tumor DNA (ctDNA) in your blood for HCC-specific fusion gene signatures. These molecular markers appear in the bloodstream at very early tumor stages — often 12–18 months before imaging can detect a tumor.
| Metric | Fusion-detect™ (MoleculeDx) | Standard AFP Test | Ultrasound Alone |
|---|---|---|---|
| Overall Accuracy | 96.7% | ~52% | ~63% |
| Sensitivity (Early Stage) | 94.2% | ~41% | ~47% |
| Specificity | 98.1% | ~87% | ~91% |
| Detects Stage I HCC | ✓ Yes | Often No | Often No |
| Invasive Procedure | None | None | Hospital Req. |
| At-Home Collection | ✓ Yes | No | No |
| Result Turnaround | 24 Hours | 24–48 hrs | 1–2 weeks |
No hidden fees. No surprise bills. And our team will verify your insurance coverage for free before you schedule.
Single liver cancer screening test with full digital report.
Single liver cancer screening test with full digital report.
The Moleculedx cancer test analyses molecular biomarkers in a patient sample to help detect, characterise or monitor cancer-related changes. The exact biomarkers and target conditions vary by test panel — full details are listed on each test’s specification page.
Moleculedx offers panels covering a range of common cancers, including but not limited to breast, lung, colorectal, prostate and gynaecological cancers. Each panel page lists the exact conditions covered and clinical context.
Depending on the test panel, samples may include blood (venous draw), saliva, urine, or, in some cases, tissue. The required sample type is clearly indicated when you book and is communicated again before sample collection.
Each Moleculedx panel is clinically validated and reports defined sensitivity and specificity values for the conditions it screens. The exact accuracy metrics are listed on the corresponding test page so you can review them before booking.
Frequency depends on the test, your age, family history and clinical risk factors. Some screening tests are recommended annually, others less frequently. Your doctor or a Moleculedx clinical advisor can help define the right interval for you.
Some panels are intended only for specific age groups, sexes or risk categories. The eligibility criteria are listed on the test page, and our team will flag any restrictions during the booking process.
Moleculedx tests use molecular signals from minimally invasive samples and are typically faster and less invasive than a tissue biopsy or imaging study. They are designed to complement, not replace, your doctor’s broader diagnostic workup, which may still include imaging or biopsy when clinically necessary.
© 2026 MoleculeDx Inc. All rights reserved.
This test is not a substitute for medical diagnosis. Consult your physician with all results.
